IHL
ALLO icon

Investment House LLC’s Allogene Therapeutics ALLO Stock Holding History

Investment House LLC’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4K Hold
16,529
– – ﹤0.01% 220
2026
Q1 		$40.3K Hold
16,529
– – ﹤0.01% 223
2025
Q4 		$22.6K Hold
16,529
– – ﹤0.01% 215
2025
Q3 		$20.5K Hold
16,529
– – ﹤0.01% 223
2025
Q2 		$18.7K Buy
+16,529
New +$22K ﹤0.01% 216

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Investment House LLC's ALLO Position: Q2 2026 in Review

Investment House LLC held its Allogene Therapeutics (ALLO) position steady in Q2 2026 at 16,529 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #220.

Investment House LLC first reported a position in ALLO in Q2 2025 and has held it in 5 quarters since. The position peaked at $40.3K in Q1 2026. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Investment House LLC held 16,529 shares of Allogene Therapeutics worth $34.4K as of Q2 2026.
  • Investment House LLC left its Allogene Therapeutics share count unchanged in Q2 2026.
  • Allogene Therapeutics made up ﹤0.01% of Investment House LLC's portfolio in Q2 2026, its #220 holding.
  • Investment House LLC first reported a position in Allogene Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Investment House LLC's Allogene Therapeutics position peaked at $40.3K in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.